Any current/future new fundraising through debt or equity?

The company does not mention any plans for new fundraising through debt or equity in the transcript. The focus is on deleveraging and reducing existing debt by recovering government receivables and using internal accruals for growth. Current cost of borrowing is around 9.7%, and significant reduction through refinancing is not expected; debt reduction will primarily come from repayments. Management aims to bring down promoter pledges to zero over the next year or so. Growth is to be funded through internal cash flows rather than fresh external funding. No indication of immediate or future fres

Any current/future capex/capital investment/strategic investment?

Current capex for the fiscal year was about INR 225 crores, slightly lower than depreciation (INR 242 crores). Most of the capex is maintenance; a small part is growth-oriented. Similar capex trends are expected for FY '25, implying maintenance-heavy investment with modest growth capex. Capacity utilization is currently around 50-55%, and the company believes it can double business over the next few years without much additional capex, mostly requiring maintenance and small growth capex. No significant net capex planned; focus appears to be on better utilization of existing capacities. Strateg

Future growth expectations in sales/revenue/volumes?

The company is targeting to double its revenue in the next 4 years. Retail business grew by 25% this year and is expected to continue growing north of 20% annually without further investment in receivables. Medium-term vision (2-3 years) is bullish on growth in 3-4 key segments including drip and sprinkler irrigation. The food business aims to grow at a double-digit rate (~15%) in FY '25, up from 5-6% growth in FY '24. Tissue culture business showed strong growth (from INR177 crores to INR250 crores) and is expected to grow faster, targeting INR1,000 crores over the next 5-6 years. C

Future growth expectations in earnings/operating earnings/profits/EPS?

The company targets double-digit revenue growth for FY '25, with potential to double revenue over the next 4 years. EBITDA margin is aimed to improve, targeting around 15% in the medium term, though full-year 15% for FY '25 is ambitious. Free cash flow improvement and deleveraging are key priorities, with substantial debt reduction expected as government projects close. Retail business growth is strong at 25%, driving earnings improvements with better cost absorption and stable receivables (26 days). Tissue culture business shows rapid growth (INR177 crore to INR250 crore), expected to

Current/ Expected Orderbook/ Pending Orders?

Current food business order book in India: approximately INR 335 crores. Global consolidated food business order book: about INR 1,000 crores. Non-food business order inflows occur continuously through dealer orders; no large accumulated order book. Project business order book (non-food): around INR 900 crores, largely institutional contractor business and existing government project business. Outstanding government projects to be completed: about INR 200-250 crores, targeted to close by FY '26. Post FY '25, company plans to reduce direct government exposure, supplying pipes/drip systems throu

Jain IrrigationQ4 FY24Industrial Products

Jain Irrigation Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹27.3Market Cap: ₹2.1K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The company is targeting to double its revenue in the next 4 years.
Retail business grew by 25% this year and is expected to continue growing north of 20% annually without further investment in receivables.
Medium-term vision (2-3 years) is bullish on growth in 3-4 key segments including drip and sprinkler irrigation.
The food business aims to grow at a double-digit rate (~15%) in FY '25, up from 5-6% growth in FY '24.
Tissue culture business showed strong growth (from INR177 crores to INR250 crores) and is expected to grow faster, targeting INR1,000 crores over the next 5-6 years.
Capital utilization is currently about 50-55%, with potential to double revenues without significant capex.
Government projects winding down; retail and institutional sales through dealers expected to drive future growth.
Positive demand outlook supported by value-added agriculture and direct benefit transfers to farmers.

Margin guidance

Category 2

The company targets double-digit revenue growth for FY '25, with potential to double revenue over the next 4 years.
EBITDA margin is aimed to improve, targeting around 15% in the medium term, though full-year 15% for FY '25 is ambitious.
Free cash flow improvement and deleveraging are key priorities, with substantial debt reduction expected as government projects close.
Retail business growth is strong at 25%, driving earnings improvements with better cost absorption and stable receivables (26 days).
Tissue culture business shows rapid growth (INR177 crore to INR250 crore), expected to contribute significantly to future profitability.
Overseas plastic sheet business and food processing segments are also expected to grow, supporting margin expansion.
FY '25 is anticipated to be a steady growth year, barring election-related or monsoon uncertainties, with overall healthier profit generation.

See what Jain Irrigation management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company does not mention any plans for new fundraising through debt or equity in the transcript.
The focus is on deleveraging and reducing existing debt by recovering government receivables and using internal accruals for growth.
Current cost of borrowing is around 9.7%, and significant reduction through refinancing is not expected; debt reduction will primarily come from repayments.
Management aims to bring down promoter pledges to zero over the next year or so.
Growth is to be funded through internal cash flows rather than fresh external funding.
No indication of immediate or future fresh equity raise was mentioned; the company is concentrating on reducing leverage and improving capital utilization.

Order book

Current food business order book in India: approximately INR 335 crores.
Global consolidated food business order book: about INR 1,000 crores.
Non-food business order inflows occur continuously through dealer orders; no large accumulated order book.
Project business order book (non-food): around INR 900 crores, largely institutional contractor business and existing government project business.
Outstanding government projects to be completed: about INR 200-250 crores, targeted to close by FY '26.
Post FY '25, company plans to reduce direct government exposure, supplying pipes/drip systems through third parties with secured financing.
Retail business operates on a cash-and-carry model with no formal order book; orders renew monthly.
Tissue culture business receives advances from farmers, which are included as part of the order book.

See what Jain Irrigation management said on order book — free account, 30 seconds.

Capex plans

Yes

Current capex for the fiscal year was about INR 225 crores, slightly lower than depreciation (INR 242 crores).
Most of the capex is maintenance; a small part is growth-oriented.
Similar capex trends are expected for FY '25, implying maintenance-heavy investment with modest growth capex.
Capacity utilization is currently around 50-55%, and the company believes it can double business over the next few years without much additional capex, mostly requiring maintenance and small growth capex.
No significant net capex planned; focus appears to be on better utilization of existing capacities.
Strategic investment focus includes building distribution networks in new agricultural and non-agricultural piping segments, especially targeting rural areas and new applications like plumbing and drainage aligned with Swachh Bharat initiatives.
Moving forward, company aims to shift government project exposure away and grow retail and institutional business segments.

Track Jain Irrigation — get its next earnings analysis in your feed

How does Jain Irrigation rank vs peers in Industrial Products?

Pro feature

ThisJain Irrigation

Rev 3Mar 2

See where Jain Irrigation sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Jain Irrigation rank in Industrial Products?

Compare Jain Irrigation against every Industrial Products company (Q4 FY24) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What Jain Irrigation's management said in earlier quarters

Others in Industrial Products this season

Monolithisch India Ltd (Q2 FY27)
Combined additional capacity: 3 lakh MT per annum; total capex approximately INR 45 crores. Key concall takeaways from Monolithisch India Ltd's Q2 FY27…
Systematic Industries Ltd (Q1 FY27)
Year-on-Year (YoY) Growth for Q4 Net Sales:** 6.0% . Key concall takeaways from Systematic Industries Ltd's Q1 FY27 earnings call — and how it ranks against…
Graphite India Ltd (Q3 FY24)
690 crore, down 1.6% y-o-y (Page 5, 9) . Key concall takeaways from Graphite India Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
Graphite India Ltd (Q4 FY24)
720 Cr, down 11.7% y-o-y (Page 4, 9) . Key concall takeaways from Graphite India Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

Compare:vs Polycab India Ltd vs Welspun Corp Ltd vs APL Apollo Tubes

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →